Jerome Fogarolo

Chief Commercial Officer (cco) at NG BIOTECH

Jerome Fogarolo has extensive work experience in the biotech and healthcare industry. Jerome is currently working as the Chief Commercial Officer (CCO) at NG BIOTECH, where they manage the international sales and marketing team and oversees product portfolios related to AMR, Infectious Diseases, and Woman Health. Prior to this, Jerome worked at bioMérieux for several years, holding various roles such as Strategic Account Director, Head of Market Managers, Global Product Manager, Regional Business Manager, and Area Business Manager. Jerome'sresponsibilities included market management, product development, sales performance optimization, and implementation of company strategies. Before joining bioMérieux, Jerome worked at Pierre Fabre as a Business Development Manager, Attaché de Direction Générale, and Product Manager.

Jerome Fogarolo completed their PharmD. degree in Pharmacy from Université Claude Bernard Lyon 1 between 1999 and 2004. Jerome then pursued an MS SIAI degree in Management from ESSEC Business School from 2004 to 2005. Further information about their education history is not provided.

Location

Charbonnières-les-Bains, France

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


NG BIOTECH

At NG Biotech, we develop, manufacture and commercialise rapid, mobile and connected diagnostics to modernize diagnosis practice worldwide. NG Biotech is a French company specialized in Research & Development, Manufacturing and Marketing of a new generation of "multiplex"​, "quantitative"​ and "connected"​ rapid diagnostics for biomarker analysis and/or therapy monitoring at the Point of Care. NG Biotech’s patented platform is rapid, mobile and connected. It allows to simultaneously analyse up to 9 biomarkers from a biological direct sample such as a single finger-prick drop of blood. The results can be sent via smartphone within five minutes. NG Biotech commercializes a range of rapid diagnostic devices covering antimicrobial resistance, women’s health and infectious disease. NG Biotech also proposes custom development partnerships with further manufacturing to support breakthrough innovative ideas with rapid diagnostic needs. Backed by a strong R&D team and 30 years of know-how, NG-Biotech is always at the hedge of technology and can conduct projects from feasibility stage up to CE marking and FDA clearance.


Headquarters

Guipry, France

Employees

51-200

Links